Sinovac Biotech Faces Nasdaq Compliance Notice Over Delayed 2024 Annual Report Filing

Reuters
23 May
Sinovac Biotech Faces Nasdaq Compliance Notice Over Delayed 2024 Annual Report Filing

Sinovac Biotech Ltd. $(SVA)$ has announced a delay in filing its annual report on Form 20-F for the financial year ending December 31, 2024. The company received a notification from Nasdaq on May 16, 2025, regarding non-compliance with Nasdaq Listing Rule 5250(c)(1) due to this delay. Sinovac is working on selecting a new independent registered public accounting firm after the resignation of Grant Thornton Zhitong. The company aims to submit a compliance plan by July 15, 2025, to address the issue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinovac Biotech Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250521444634) on May 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10